Targeted radiation boost for brain tumors
Part of Cancer clinical trials.
This trial tests a special radiation boost that targets low-oxygen areas of the brain tumor during standard radiation therapy. It may help control the tumor better for people with newly diagnosed or recurrent glioblastoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a suspected or confirmed glioblastoma (a type of brain tumor) that is either new or has come back.
- You are able to have surgery to remove the tumor, or you are getting radiation and still have visible tumor.
- You are generally able to care for yourself (Karnofsky score above 50).
- Your liver and kidney function are within acceptable limits.
- If you are having repeat radiation, it has been at least 3 months since your last brain radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a more focused, stronger dose of radiation can improve outcomes for people 65 and older with newly diagnosed glioblastoma. It compares this approach to standard radiation to see if it's safe and effective.
This trial is testing a new way to deliver radiation therapy to a smaller area of the brain after surgery for glioblastoma. The goal is to see if this more focused approach can treat the tumor effectively while possibly reducing side effects and protecting healthy brain tissue.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This trial combines a new therapy (sonodynamic therapy) with standard radiation and chemotherapy for glioblastoma. It aims to see if this approach is safe and how well it works for people who have just been diagnosed and had surgery.
This study tests a new way to deliver radiation therapy for a type of aggressive brain tumor called glioblastoma or grade 4 astrocytoma. Patients get MRI scans during each treatment so the radiation beam can be adjusted precisely, aiming to improve outcomes.
This trial tests a new way of giving radiation therapy for glioblastoma (a type of brain cancer) using a machine that combines MRI imaging with radiation. The goal is to safely intensify the treatment and improve outcomes.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.